Met.Extra Group (CHIX:METM) Research & Development: €0.00 Mil (TTM As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

CHIX:METM Met.Extra Group CHIX:METM
78 GF Score
Price €5.10
GF Value €5.99
! 6 Warning Signs
View Full Analysis

What is Met.Extra Group Research & Development?

Met.Extra Group CHIX:METM 78 Research & Development is €0.00 Mil as of Dec. 2025. GuruFocus rates CHIX:METM with a GF Score™ of 78/100 and a GF Value™ of €5.99. The stock has 6 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Met.Extra Group's Research & Development for the six months ended in Dec. 2025 was €0.00 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 was €0.00 Mil.

Met.Extra Group  (CHIX:METm) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Met.Extra Group Research & Development Related Terms

Met.Extra Group Research & Development Historical Data

* Premium members only.

The historical data trend for Met.Extra Group's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Met.Extra Group Research & Development Chart

Met.Extra Group Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Met.Extra Group Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
CHIX:METM
78GF Score
Met.Extra Group CHIX:METM
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Met.Extra Group Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was €0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of €0.00 Mil mean?
Met.Extra Group (CHIX:METM) has a Research & Development of €0.00 Mil as of Dec. 2025. Research and development expense is the total cost for research and development activities. View historical data on Met.Extra Group and its competitors.
Is Met.Extra Group's Research & Development too high?
Met.Extra Group's current Research & Development is €0.00 Mil. Overall, Met.Extra Group has a GF Score™ of 78/100, reflecting its overall financial health beyond just this single metric.
How does Met.Extra Group's Research & Development compare to BLK and BX?
Met.Extra Group's Research & Development of €0.00 Mil can be compared against companies in the Asset Management industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for an Asset Management company?
A good Research & Development depends on the Asset Management industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Met.Extra Group and its competitors. Met.Extra Group's current Research & Development is €0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Met.Extra Group stock overvalued right now?
Met.Extra Group (CHIX:METM) has a current Research & Development of €0.00 Mil. The stock's GF Value™ is €5.99, compared to a current price of €5.10 — trading 14.9% below its estimated fair value. The current Research & Development is €0.00 Mil. Met.Extra Group's overall GF Score™ is 78/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Met.Extra Group (CHIX:METM), the current Research & Development is €0.00 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Met.Extra Group (CHIX:METM) Overvalued in 2026?

Based on GuruFocus' analysis, Met.Extra Group stock appears to be undervalued. The current stock price of €5.10 is trading 14.9% below its estimated GF Value™ of €5.99.

Key valuation signals for CHIX:METM:

  • Research & Development: €0.00 Mil
  • GF Value™: €5.99 vs. price of €5.10 (14.9% below fair value)
  • GF Score™: 78/100 with 6 warning signs

No single metric tells the full story. See the CHIX:METM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Met.Extra Group Business Description

Other Exchanges MET:Italy
Address Corso Monforte 7, Milano, ITA, 20122
Met.Extra Group, formerly TitanMet SpA is an Italian investment company. Its objective is to carry out a wide-ranging strategic project aimed at future investments in assets or financial instruments that do not involve the acquisition of control in the realities of interest. It is also involved in the development of synergies and implementation of subsequent integrations, acquisitions, spin-offs, and other interventions, as well as provides advisory services.
78GF Score

Get the complete analysis for CHIX:METM

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€5.10
Price
€5.99
GF Value